Upcoming Agents for the Treatment of Schizophrenia

  title={Upcoming Agents for the Treatment of Schizophrenia},
  author={D. Bishara and Dr David Taylor},
  • D. Bishara, Dr David Taylor
  • Published 2012
  • Medicine
  • Drugs
  • Since the introduction of a group of atypical antipsychotics in the 1990s, there has been a decline in the rate of new antipsychotics being introduced into clinical practice. However, with increasing safety and efficacy concerns over currently available drugs and a dearth of options available for atypical depot formulations, there is a considerable need for the development of new formulations and agents. This review examines the profile of seven antipsychotic drugs currently in the premarketing… CONTINUE READING
    78 Citations
    Evaluation of the clinical efficacy of asenapine in schizophrenia
    • 19
    Critical appraisal of lurasidone in the management of schizophrenia
    • 22
    • PDF
    New atypical antipsychotics for schizophrenia: iloperidone
    • 39
    • PDF
    Paliperidone Extended-Release: Safety and Tolerability from a Metabolic Profile Perspective
    • 7
    • Highly Influenced
    Neurobiological Background for the Development of New Drugs in Schizophrenia
    • 40
    Iloperidone: A new drug for the treatment of schizophrenia.
    • S. Arif, M. Mitchell
    • Medicine
    • American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
    • 2011
    • 32
    Blonanserin: a review of its use in the management of schizophrenia.
    • 87
    Once-monthly paliperidone injection for the treatment of schizophrenia
    • D. Bishara
    • Medicine
    • Neuropsychiatric disease and treatment
    • 2010
    • 52
    • PDF


    Pharmacological and molecular targets in the search for novel antipsychotics
    • 41
    Risperidone in the treatment of schizophrenia.
    • 81
    • PDF
    The Role of Serotonin in Antipsychotic Drug Action
    • H. Meltzer
    • Psychology, Medicine
    • Neuropsychopharmacology
    • 1999
    • 657
    • Highly Influential
    • PDF
    A review of the effect of atypical antipsychotics on weight
    • H. Nasrallah
    • Psychology, Medicine
    • Psychoneuroendocrinology
    • 2003
    • 232
    The pipeline and future of drug development in schizophrenia
    • 164
    • PDF
    Effectiveness of antipsychotic drugs in patients with chronic schizophrenia.
    • 4,774
    • PDF
    5-HT2 and D2 receptor occupancy of olanzapine in schizophrenia: a PET investigation.
    • 335
    Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles
    • 456
    • PDF
    Do Novel Antipsychotics Have Similar Pharmacological Characteristics? A Review of the Evidence
    • 662
    • PDF
    Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder.
    • 534
    • PDF